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Abstract
The  population  of  children  and  young adults  requiring  a  cardiac  pacing  device  has  been 
consistently increasing. The current generation of devices are small with a longer battery life, 
programming capabilities that can cater to the demands of the young patients and ability to 
treat brady and tachyarrhythmias as well as heart failure. This has increased the scope and 
clinical indications of using these devices. As patients with congenital heart disease (CHD) 
comprise majority of these patients requiring devices, the knowledge of indications, pacing 
leads and devices, anatomical variations and the technical skills required are different than that 
required in the adult population. In this review we attempt to discuss these specific points in 
detail  to  improve  the  understanding  of  cardiac  pacing  in  children  and  young  adults.  
Introduction
Pediatric  pacing  has  progressed  substantially  since  the  first  implant  in  a  14  yr  old  with 
myocarditis in 1962 .[1] Current pacemakers have a much smaller size, longer battery life, 
multiple pacing and sensing modalities, and therapeutic capabilities in the form of detecting 
and treating tachy-arrhythmias as well improving the contractility of a failing heart.  Hence 
there  is  an  increasing  demand  for  pediatric  pacing  devices  due  to  increase  in  clinical 
indications, technological advances and innovative techniques. However based on the 2010 
Health Care Cost and Utilization Project (HCUP) database, only 0.6% of all the implanted 
cardiac  devices  have  been  in  the  pediatric  population.  The  number  of  pediatric  patients 
receiving pacemaker implantation has been stable over the past decade; however there has 
been a 4-fold rise in the number of patients receiving defibrillators and biventricular devices.
[2]
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Indications  
a.  Permanent  Pacemakers                                       
The most common indications for permanent pacemaker implantation in children, adolescents, 
and patients with congenital heart disease are:                                                 
1)  Symptomatic  sinus bradycardia  related  to sinus node dysfunction,  associated with poor 
cardiac output or to prevent episodes of recurrent atrial tachycardias.                        
2)  Advanced  second-  or  third-degree  AV  block,  either  congenital  or  postsurgical,  when 
associated  with  low  cardiac  output,  ventricular  dysfunction,  complex  ventricular  ectopy, 
syncope or potential of recovery is minimal, especially after cardiac surgery.[3]               
Important considerations in children and young adults are 1) an increasing number of young 
patients are long-term survivors of complex surgical procedures for congenital heart defects 
that  result  in  palliation  rather  than  correction  of  circulatory  physiology.  The  residua  of 
impaired ventricular function and abnormal physiology may result in symptoms due to sinus 
bradycardia  or  loss  of  AV  synchrony  at  heart  rates  that  do  not  produce  symptoms  in 
individuals  with  normal  cardiovascular  physiology.  Hence,  the  indications  for  pacemaker 
implantation in these patients need to be based on the correlation of symptoms with relative 
bradycardia rather than absolute heart rate criteria. 2) The clinical significance of bradycardia 
is age dependent; e.g. a heart rate of 45 bpm may be a normal finding in an adolescent, the 
same rate  in  a  newborn or  infant  indicates  profound bradycardia.  3)  Significant  technical 
challenges may complicate device and transvenous lead implantation in very small patients or 
those with abnormalities of venous or intracardiac anatomy. 4) As there are no randomized 
clinical trials of cardiac pacing in pediatric or congenital heart disease patients, the level of 
evidence for most recommendations is consensus based.                                            
b.  Implantable  Cardioverter-Defibrillators  (ICDs)                                      
ICDs are recommended for patients who have survived an episode of cardiac arrest, patients 
with poor cardiac function with evidence of moderate to severe heart failure, patients with 
inducible  ventricular  dysrhythmia  in  a  setting  of  symptomatic  CHD and in  patients  with 
genetic  cardiomyopathy.  Sudden  cardiac  death  (SCD)  in  childhood  and  adolescence  is 
associated  with  congenital  heart  disease,  cardiomyopathies,  and  genetic  arrhythmia 
syndromes. There is paucity of clinical experience and data regarding ICD implantation for 
primary prevention of SCD in young patients and therefore recommendations are based on 
extrapolation of data from adult studies. Unexpected sudden death is reported in 1.2% to 3.0% 
of patients per decade after surgical treatment of tetralogy of Fallot, with risk factors including 
ventricular  dysfunction,  QRS  duration,  and  atrial  and  ventricular  arrhythmias.[4]  A 
significantly greater risk of SCD has been identified for patients with transposition of the great 
arteries  or aortic  stenosis, with most cases presumed to be due to a malignant  ventricular 
arrhythmia associated with ischemia, ventricular dysfunction, or a rapid ventricular response 
to  atrial  flutter  or  fibrillation.[5]  The  lack  of  prospective  and  randomized  clinical  trials 
precludes  exact  recommendations  regarding  risk  stratification  and  indications  for  ICD 
implantation for primary prevention of SCD in patients with postoperative congenital heart 
disease and ventricular dysfunction. ICDs may also be considered as a bridge to orthotopic 
heart  transplantation  in  pediatric  patients,  particularly  given  the  longer  times  to  donor 
procurement  in  younger  patients.[6]                                          
c. Biventricular pacing (Cardiac Resynchronization Therapy, CRT)                             
There are no randomized multicenter studies regarding use of CRT in pediatrics and young 
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adults. The limited worldwide pediatric experiences has shown that CRT is useful in select 
younger  patients  with  clinical  improvements  comparable  to  adult  patients  and,  in  some 
instances, can delay or remove the need for heart transplant.[7]. The current guidelines for 
adults suggests biventricular pacing for patients with wide QRS rhythm of left bundle branch 
block  morphology  with  ejection  fraction  ≤  35% and  in  functional  heart  failure  class  2-3 
despite medical management.[8] These are not easily extrapolated to the pediatric population. 
The incidence of ischemic heart disease is very low in pediatric patients. Younger patients 
typically require pacing therapy for bradycardia associated with congenital heart block (often 
with normal ventricular contractility) or progressive damage to the atrioventricular conduction 
system following surgical  repair  of various structural  congenital  heart  defects.             
Technical aspects of device implantation                                                           
The implantation of devices in children and young adults can be challenging especially in 
view of anatomical variations due to congenital defects and surgical procedures to repair the 
heart  defects.                                          
Anatomical  considerations                                   
It is important to understand the anatomy and have a thorough knowledge of any underlying 
heart  defects,  presence  of  intracardiac  shunts  and  type(s)  of  surgical  procedure(s)  if  any 
performed in the past. Venography may help define presence or absence of left superior vena 
cava, any obstruction, or anomalies as well as patency of the vasculature if previous leads are 
present. Patients with d-transposition of the great arteries (d-TGA) with atrial switch operation 
have surgical baffles connecting the superior vena cava (SVC) and inferior vena cava to the 
pulmonary  (left)  ventricle.  If  placement  of  a  lead  is  anticipated  and  there  is  presence  of 
narrowing across the superior baffle,  it  is useful to consider stent angioplasty of the SVC 
baffle prior to lead implantation. Patients with previous cardiac surgery may have their right 
atrial appendage amputated at the time of canulation. In patients with Fontan palliation for 
single ventricular physiology, an atrial lead may be implanted transvenously in patients with 
atrio-pulmonary  connection  or  lateral  tunnel  palliation  (but  not  the  extracardiac  conduit), 
keeping in mind that they have a passive venous flow circulation. The presence of left SVC 
without  a  bridging vein can  make the implantation  technically  challenging  albeit  possible 
(Figure 1). Future growth of the patient must be taken into account during lead implantation.  
Route  of  lead  implantation                                         
The  pacing  and defibrillator  leads  can  be  implanted  via  the  transvenous  (endocardial)  or 
surgical  (epicardial)  route.  The choice  of  route is  dependent  upon the size of  the patient, 
anatomy and surgical  procedures  performed.  The primary  risk  factor  for  obstruction  after 
pacemaker lead implantation in children was found to be related to the size of the lead as 
compared to the body surface area at implantation. A ratio > 6.6 mm2/m2 was found to best 
predict venous obstruction, with a sensitivity of 90% and specificity of 84%. This data can be 
used to aid the physician in selection of a single or dual chamber lead system appropriate for 
the patient's size, thus decreasing the risk of venous obstruction, and hence preserving venous 
access.[9] Patient age, body size and lead characteristics at implant do not appear to predict 
occlusion  in  patients  aged  over  3  years.[10]  For  patients  less  than  10-15  kilograms, 
intracardiac shunt lesions, prosthetic tricuspid valve and circumstances where the anatomy or 
surgical palliation precludes access via the transvenous route, epicardial implantation is the 
route  of  choice.  Epicardial  lead  implantation  requires  sternotomy  or  thoracotomy  or 
subxiphoid approach, and is associated with higher chronic stimulation threshold, higher lead 
failures  and fractures  and early  depletion  of  battery  life.[11-13]  However  it  preserves  the 
venous access for future use. There have been case reports and small series of patients less 
than 10  kg  who  have  successfully  undergone  transvenous  lead  implantation.[14-16] 
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Endocardial lead placement offers the advantages of avoidance of thoracotomy, lower pacing 
thresholds,  and a  lower  incidence  of  lead  fractures.  However  its  disadvantages  include  a 
greater risk of lead dislodgment, venous occlusion, embolic vascular events, and endocarditis.
[17]
Figure 1: Dual chamber pacemaker lead implantation in a patient with left SVC without a bridging vein.
Programming  of  the  device                                           
Children have faster resting heart  rates  than adults  and higher  peak heart  rates  -  it  is  not 
unusual for infants to have resting heart rates between 120 and 150 beats/min, and it is easy 
for children of all ages to attain sinus rates in excess of 200 beats/min during active play. 
Many pacemakers cannot pace at or track sinus rates beyond 180 beats/min and rates with 
defibrillators  are  even  lower.  These  limits  to  the  maximum  tracking  rate  can  result  in  a 
substantial  decrease  in  exercise  performance,  peak  oxygen  consumption  and  anaerobic 
threshold.[18] In addition,  higher heart  rates result  in increased battery utilization that can 
significantly impact the longevity of the pulse generators.                                      
Use of single chamber vs.  dual chamber ICD                                        
Younger  patients  have  higher  sinus  rates  during  exertion  and  increased  frequency  of 
supraventricular tachycardias especially in patients with congenital heart defects. It has been 
reported  that  30%  of  patients  with  ICDs  and  congenital  heart  disease  will  develop 
supraventricular  tachyarrhythmias  during  follow-up.[19,20]  Meta-analysis  of  data  from 
patients  with  ICDs  reveals  evidence  that  in  those  with  dual-chamber  ICD's,  arrhythmia 
discrimination shows improved detection specificity without jeopardizing sensitivity; however 
the proportion of patients with inappropriate  therapy was still  approximately 20%, despite 
sophisticated arrhythmia discrimination.[21] There is no evidence that empirical use of any 
dual-chamber pacing approach improves mortality,  quality of life, or reduces heart failure, 
ventricular tachyarrhythmia, or atrial arrhythmia. Moreover, the pulse generator longevity is 
about one-third less in dual- versus single-chamber ICDs.[22] In the case of obligatory pacing 
for symptomatic sinus node dysfunction, a dual-chamber strategy for minimal pacing at all 
chamber  levels  is  recommended.[23]                                          
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Technique  of  device  implantation                                       
The handedness of the patient is determined as the device is preferably implanted on the non-
dominant  side.  The  procedure  is  usually  performed  under  general  anesthesia.  Antibiotic 
coverage is provided during and immediately after the procedure.[24] Based on the size of the 
patient and the device as well as cosmetics, the site of implantation is chosen. Subcutaneous 
pocket  or  submuscular  pocket  is  created  and  rinsed  with  antibiotic  solution.  There  is  no 
difference in the pacing, sensing thresholds or defibrillation thresholds for ICDs in either the 
subcutaneous or submuscular implantation.[25] Some prefer the submuscular implantation in 
extremely thin individuals with minimal fat tissue to prevent device erosion and in patients 
with  or  at  risk  of  Twiddler's  syndrome.  The  vein  is  accessed  with  modified  Seldinger 
technique or a venous cutdown. The number of leads decides the number of access sites in the 
veins. We attempt to access the axillary vein to avoid the complication of subclavian crush at 
the site of the ligament, reduce the risk of pneumothorax or hemothorax and less cumbersome 
extraction if necessary. The axillary vein is accessed by creating a roadmap by either placing a 
pacing catheter or by performing a venogram in the innominate vein or the cubital vein from a 
peripheral venous line. The ventricular leads are usually implanted first. The RV septum is 
usually targeted with manually shaping the stylets and the positioning confirmed on a biplane 
fluoroscope. The RV low septum is targeted in most of the patients with a routine curve to the 
stylet that lets it across the tricuspid valve followed by a posterior smaller curve near the tip of 
the stylet to obtain a septal position. If implanting a LV lead, the coronary sinus is accessed 
with special sheaths, an angiogram performed to delineate the anatomy and choose the target 
vein. Once the target vein is identified, the LV lead is implanted over a guide wire. If a dual 
chamber pacemaker is planned, an atrial lead is implanted next. The site of the Bachmann's 
bundle  is  preferred  as  it  is  associated  with  lower  far  field  R  wave  sensing,  atrial 
synchronization  and  prevention  of  atrial  arrhythmias.[26-28]  The  Bachmann's  bundle  is 
located in the posterior high right atrial septum near the superior vena cava. The site is easily 
accessible using long sheaths and manually shaped stylets that have a smaller curve than the 
routine J-shaped stylet for positioning the lead in the right atrial appendage.[29] Pacing and 
sensing thresholds are determined. Pacing from each lead at 10V is performed to determine 
any  potential  phrenic  nerve  stimulation.  The  leads  are  secured  with  stay  sutures  in  the 
musculature and around the pacing lead sleeves and attached to the generator. If placing an 
ICD, the defibrillation threshold (DFT) is obtained by the upper limit of vulnerability (ULV) 
testing or the binary search method. The upper limit of vulnerability (ULV) is the weakest 
shock strength at or above which VF is not induced when the shock is delivered at any time 
during the vulnerable period, which is the portion of the cardiac cycle during which shocks 
induce  VF.  ULV testing  can  be  applied  at  ICD implant  to  confirm a  clinically  adequate 
defibrillation safety margin without inducing VF in 75%–95% of ICD recipients.[30]  The 
binary search algorithm uses step-wise successive shock energies depending on the success of 
the previous shock. The lowest energy that successfully terminates the ventricular tachycardia 
is  termed as the DFT.[31] The generator  is  secured and the incision is closed in multiple 
layers. The ipsilateral arm is immobilized in a sling for a period of 1-2 weeks to prevent lead 
dislodgement. The incision is kept dry for 7-10 days.                                       
Based on variations in anatomy, the lead implantation technique may have to be revised. In 
patients with high DFTs at the time of ICD implantation,  additional coils or subcutaneous 
array  are  implanted.[32]  The  placement  of  additional  coils  can  be  in  the  coronary  sinus, 
azygous vein, or the left innominate or axillary vein (Figure 2). Implanting the device in the 
left axillary region has also been postulated to reduce the DFT.[33] Use of medications like 
Sotalol  has been reported to lower the DFT .[34,35] In some group of patients  a 'hybrid' 
approach to lead implantation is performed. If biventricular pacing is contemplated in patients 
with d-TGA with atrial switch palliation, a mini-sternotomy or thoracotomy is used to implant 
the systemic (RV) ventricular epicardial lead that is tunneled to the pocket where the generator 
with the transvenous leads is placed. In very small  patients,  ICD  is  implanted  using  a 
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pericardial patch or a coil in the pericardial space with a bipolar sensing lead on the ventricle  
and implantation of the device in the abdomen.[36]                               
Figure 2: Use of an ICD coil in the left axillary vein in a patient with right sided generator implant to lower the 
DFTs. The atrial lead is in the posterior high right atrial septum near the Bachmann’s bundle.                    
Follow-up
The patient and the device are assessed prior to discharge, in 1- 2 weeks for incision check, at  
2- 3 months to assess chronic pacing thresholds and cardiac function (because of the risk of 
pacing-induced cardiac dysfunction), and then  6 months to yearly.  Patients are advised to 
transmit data using the remote monitoring services on a 3 monthly basis or if any change in 
clinical status occurs. The remote monitoring is intensified to a monthly basis in pacemaker 
dependent patients and in patients nearing end of battery life. Any patient experiencing an 
ICD discharge is recommended to follow up in the closest emergency room to evaluate the 
appropriateness  of  the  discharge,  need  for  in-patient  admission,  or  pharmacological 
intervention.  Chest  radiographs  have  been  advised  on  a  yearly  basis  in  small  children  to 
recognize any growth related lead damage. Echocardiograms are performed on an annual basis 
to  evaluate  valvular  and  cardiac  function.  Stress  test  is  recommended  to  assess  exercise 
tolerance,  maximal  heart  rates  achievable,  assess  the  rate  response  settings,  and  exercise 
related  arrhythmias  for  fine  tuning  of  the  device  for  allowing  maximal  functionality  in 
children  and  young  adults.                                          
Complications
Device implantation data using the Kids' Inpatient database from 1997-2006 revealed specific 
complication  rates  for  all  device  types  were  pneumothorax  2.2%,  hematoma  3.3%, 
endocarditis/  pericarditis  1.1%,  surgical  infection  2.4%  and  death  1.7%.  Biventricular 
pacemakers have the highest percentage of acute complications (42.3%) whereas pacemakers 
(17.3%)  and  defibrillators  (16.8%)  were  lower.  Pacemakers  had  higher  patient-related 
complications (11.2%) in comparison to ICDs and biventricular pacemakers and ICDs had 
higher  device-related  complications  (11.5%)  in  comparison  to  the  pacemakers  and 
biventricular  pacemakers.[2]                                              
Techniques  of  implantation  to  aid  extraction                                      
With the technological advances making more devices compatible for younger patients and 
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the  increasing  population  of  adult  congenital  heart  defect  patients  requiring  device 
implantation, the need for revision or extraction will continue to increase. Considering lead 
implantation techniques and hardware that lend them to easier extractions would be helpful. 
Older lead age, a lead in the ventricular position, and polyurethane lead insulation were found 
to be independent  predictors  of  the decreased likelihood of  a  simple  extraction.[37]  Long 
implantation time, lack of operator experience, ICD lead type and female gender are possible 
risk factors for life-threatening complications.[38] Implantation durations of less than 3 years 
had a success rate of 100% whereas it was only 65.5% in those that were older than 3 years,  
most probably due to robust fibrosis in the young patient population.[39] Medial subclavian 
vein  approaches  are  discouraged due to  the  risk of  crush requiring  subsequent  and likely 
difficult extraction. In the dual coil leads, the SVC coil stimulates more aggressive fibrosis 
with high risk for vascular tear at time of extraction.[40] Use of leads that are appropriately 
sized for the patient will reduce the amount of extra lead left in the pocket that may need to be 
dissected.  Leads that are constructed well  so as not to fall  apart  easily, and leads that are 
isodiametric with active fixation, are likely to be more easily and completely removed .[41] If 
passive fixation leads are to be used, shorter tine length will make extraction easier. As the IS-
4 standard becomes widely available for ICD leads, this will eliminate the "yoke" on these 
leads, making dissection easier as well. The use of ICD leads that use coils backfilled with 
medical adhesive, or that are covered with Gortex™ markedly reduces the tissue in-growth 
and  facilitates  easier  and  safer  extraction.[41,42]                                  
Conclusion
The utility of cardiac devices in the pediatric population is increasing due to technological 
advances as well as improved survival of patients with congenital heart defects. Symptomatic 
bradyarrhythmias, risk of sudden death, heart failure are the broad indications for implantation 
of a cardiac device. The selection of device and leads as well as the technique of implantation 
are based on the patient size and anatomy. Careful selection of the device, leads and technique 
can help reduce complications associated with the implantation as well as aid in extraction of 
the  devices  in  the  long  term.                                           
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